Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss ...

Rybelsus (oral semaglutide by Novo Nordisk) is used for type 2 diabetes, so the expense is usually ongoing, not a one-time ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

The pill was approved by the US ‌Food and Drug Administration last ‌month, a boon to Novo Nordisk as it looks to regain ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) on Tuesday provided an update on its Phase 1b, 12-week chronic study GLP-1-H24-4, recently completed in Australia, focusing on 4 DehydraTECH ( DHT) study arms ...